Wow...check out this Chipotle ad.

[proverbialwisdom]

69. Read for the FACTS, disregard the rest.

MUST READ: http://www.democraticunderground.com/101672031

http://najms.net/wp-content/uploads/v06i03.pdf#page=34

Preface to the special issue of autism

Autism spectrum disorder (ASD), the fastest-growing complex neurodevelopment disorder, continues to rise in its prevalence, now affecting up to 1 in 50 children in the USA, and averaging 1% globally, according to the latest CDC report. More children will be diagnosed with ASD this year than with AIDS, diabetes & cancer combined in the USA. ASD costs the nation $137 billion a year and this debt is expected to increase in the next decade. Hence, ASD has become a huge healthcare burden and global threat, categorized by the CDC as a national public health crisis.

ASD is characterized by social-communication impairment, and restricted, repetitive, and stereotyped patterns of behavior, which cause significant disability for those affected. With its etiology still largely unknown, and its pathophysiology poorly understood, ASD currently has no universally accepted therapy. ASD is affecting more and more families; unmet services and limited resources need to be addressed urgently. Researchers, clinicians, healthcare providers, social agencies and government need to coordinate efforts to develop more effective treatments and a satisfactory continuum of care, across the lifespan. Ultimately, a cure needs to be sought for the various subtypes of ASD that exist.

The current issue of North American Journal of Medicine and Science (NAJMS) represents a continuation of our previous two special issues on autism (NAJMS Vol. 5 Issue 3 and Vol. 4 Issue 3) published in July 2012 and July 2011, respectively. In this issue, we are honored to have another panel of expert researchers and clinicians on the frontlines of ASD research and treatment to present their newest research findings and views from different perspectives.

This issue of NAJMS consists of five original research articles, two comprehensive reviews, one case report and two commentary articles, covering topics in genetics, pathogenesis, metabolic disorder biomarkers of ASD, and a clinical study, that bring into focus our newest understanding and treatment strategies.

<>

The data presented in Dr. Mumper’s review of the medical literature, suggests that ASD may be impacted by environmental toxicants, duration of breastfeeding, gut flora composition, nutritional status, acetaminophen use, vaccine practices and use of antibiotics and/or frequency of infections. In her current general pediatric practice (Advocates for Children), she has noted a modest trend toward a lower prevalence of ASD than in her previous pediatric practice or recent prevalence estimates from the CDC.

<>

Xuejun Kong, MD
Editor-in-Chief, NAJMS
Department of Medicine
Beth Israel Deaconess Medical Center
Harvard Medical School

Christopher J. McDougle, MD
Guest Editor, NAJMS
Lurie Center for Autism Massachusetts General Hospital
Harvard Medical School

Again, read for the FACTS, disregard the rest.

http://adventuresinautism.blogspot.com/2013/07/welcome-ernest-hancock-listeners.html
http://www.ageofautism.com/2013/09/iaccs-matt-carey-and-the-november-autism-hearing.html
http://usatoday30.usatoday.com/news/health/story/health/story/2011/05/One-in-six-children-have-a-developmental-disability/47467520/1